Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Intangibles: 2009-2024

Historic Intangibles for Gyre Therapeutics (GYRE) over the last 9 years, with Dec 2024 value amounting to $701,000.

  • Gyre Therapeutics' Intangibles rose 830.77% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year increase of 830.77%. This contributed to the annual value of $701,000 for FY2024, which is 16.64% up from last year.
  • Gyre Therapeutics' Intangibles amounted to $701,000 in FY2024, which was up 16.64% from $601,000 recorded in FY2023.
  • In the past 5 years, Gyre Therapeutics' Intangibles registered a high of $2.0 million during FY2022, and its lowest value of $601,000 during FY2023.
  • Over the past 3 years, Gyre Therapeutics' median Intangibles value was $701,000 (recorded in 2024), while the average stood at $1.1 million.
  • As far as peak fluctuations go, Gyre Therapeutics' Intangibles plummeted by 70.51% in 2023, and later grew by 16.64% in 2024.
  • Yearly analysis of 3 years shows Gyre Therapeutics' Intangibles stood at $2.0 million in 2022, then slumped by 70.51% to $601,000 in 2023, then increased by 16.64% to $701,000 in 2024.